Author:
Ranjbar-Niavol Fazeleh,Rezaei Niloufar,Zhao Ying,Mirzaei Hamed,Hassan Moustapha,Vosough Massoud
Abstract
Enforcing a well-differentiated state on cells requires tumor suppressor p53 activation as a key player in apoptosis induction and well differentiation. In addition, recent investigations showed a significant correlation between poorly differentiated status and higher expression of NANOG. Inducing the expression of NANOG and decreasing p53 level switch the status of liver cancer cells from well differentiated to poorly status. In this review, we highlighted p53 and NANOG cross-talk in hepatocellular carcinoma (HCC) which is regulated through mitophagy and makes it a novel molecular target to attenuate cancerous phenotype in the management of this tumor.
Reference92 articles.
1. A global view of hepatocellular carcinoma: trends, risk, prevention and management;Yang;Nat Rev Gastroenterol Hepatol,2019
2. Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy;Singal;Nat Rev Clin Oncol,2023
3. Current epidemiology in hepatocellular carcinoma;Konyn;Expert Rev Gastroenterol Hepatol,2021
4. Targeted therapies for hepatocellular carcinoma treatment: A new era ahead—A systematic review;Damaskos;Int J Mol Sci,2022
5. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers;Wang;Cancer Metastasis Rev,2023
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献